Related Experiment Video
Updated: Dec 24, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Personalization of Treatment is the Way Forward in Care and Trials
1University of California, San Francisco, San Francisco, California. Laura.Esserman@ucsfmedctr.org.
Abstract:
It has been demonstrated that, in early breast cancer, there is no survival benefit to additional treatment once a patient has achieved a pathologic complete response (pCR). Together with the well-established prognostic association between pCR and survival, this presents a strong rationale for escalation/deescalation of neoadjuvant treatment based upon response.See related article by Spring et al., p. 2838.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Dosage Regimen: Individualization
Blinding
Clinical Trials
There are four phases in a clinical trial. A phase one...
Patient-centered Care
Targeted Cancer Therapies
There are several types of targeted therapies against...

